I am a
Home I AM A Search Login

Papers of the Week

Papers: 27 Aug 2022 - 2 Sep 2022

Human Studies, Pharmacology/Drug Development


2022 Sep 01

Neurol Ther

Circulating Insulin-Like Growth Factor 1 Levels and Migraine Risk: A Mendelian Randomization Study.


Abuduxukuer R, Niu P-P, Guo Z-N, Xu Y-M, Yang Y
Neurol Ther. 2022 Sep 01.
PMID: 36048332.


Preclinical studies have indicated insulin-like growth factor 1 (IGF1) as a novel therapeutic target in the treatment of migraines. We aimed to investigate the causal effect of circulating IGF1 levels on migraine risk using the two-sample Mendelian randomization method.